There has been a great deal of discussion about peptides as a mainstay in therapeutic options for acute and chronic conditions. The environment and landscape are quickly unfolding to embrace peptides as another treatment option. Currently, there are 140 clinical trials involving peptides, and there are 500 more pre-clinical trials that will start up soon. As of today, over 60 peptide drugs are FDA approved. They are potent, safe, and specific, with little to no side effects. Peptides are essentially made of amino acids. When certain amino acids are combined, they can create different kinds of peptides. When peptides are connected, they form different proteins. On a historical note, Insulin was the first peptide introduced to the market back in 1921.